3.3 Changes in the ILC2 prevalence in blood and in the LMK-CT score before and after ESS
The ILC2 prevalence in postoperative blood was examined at an average of 6 months after ESS, and the postoperative LMK-CT score was examined at an average of 14 months after ESS. The ILC2 prevalence in blood and the LMK-CT score were significantly decreased after ESS in the eCRS and non-eCRS patients (Figure 3A and B). The ILC2 prevalence in postoperative blood was significantly decreased in the good outcome group, but not in the poor outcome group (Figure 4).